Cambium Bio Limited Cambium Bio Limited

Cambium Bio Limited

CMB

Rank in Stocks #29933
Cambium Bio Limited, a clinical-stage regenerative medicine company, focuses on... Cambium Bio Limited, a clinical-stage regenerative medicine company, focuses on developing biologics for ophthalmology and tissue repair applications. The company provides lead product candidate is Elate Ocular for the treatment of dry eye disease. The company also develops Progenza, a stem cell platform for knee osteoarthritis and other tissue repair indications; and Sygenus, for wound healing indications. Cambium Bio Limited is headquartered in Bella Vista, Australia.
Share Price
$0.24638768
Last synced: 2026-11-12
Market Cap
$6.26M
Change (1 day)
-0.35%
Change (1 year)
-25.30%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
Operating Margin for Cambium Bio Limited (CMB)
Operating Margin as of November 2026 TTM: -502.93%
According to Cambium Bio Limited's latest financial reports, its current operating margin (TTM) is -502.93%. At the end of 2025 the company had an operating margin of -641.09%.
Operating Margin history for Cambium Bio Limited from 2011 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -502.93% -21.55%
2025 -641.09% -99.75%
2024 -255,131.57% 0.00%
2023 0.00% 0.00%
2022 0.00% -100.00%
2021 23.15% -111.75%
2020 -196.99% 0.00%
2019 0.00% -100.00%
2018 -1,271.90% -13,131.76%
2017 9.76% -102.63%
2016 -371.26% -32.55%
2015 -550.41% -5.94%
2014 -585.18% 33.32%
2013 -438.93% 2.34%
2012 -428.90% 25.14%
2011 -342.73% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
-195.39% -99.61%
US
33.87% -100.07%
US
-116.04% -99.77%
US
25.57% -100.05%
AU
31.23% -100.06%
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about Cambium Bio Limited's operating margin

What is Cambium Bio Limited's operating margin?

Cambium Bio Limited's operating margin is -502.93%, as of Nov 2026.

What was Cambium Bio Limited's operating margin in 2025?

In 2025, Cambium Bio Limited's operating margin was -641.09%, compared with -255,131.57% in 2024.

How has Cambium Bio Limited's operating margin changed since 2020?

From 2020 to 2025, Cambium Bio Limited's operating margin was highest in 2021 (23.15%) and lowest in 2024 (-255,131.57%).

How does Cambium Bio Limited's operating margin compare with similar companies?

Cambium Bio Limited's operating margin (-502.93%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 33.87%.